• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KU-PARP14 轴通过 MRE11 和 EXO1 对停滞复制叉处的 DNA 切除进行差异调节。

The KU-PARP14 axis differentially regulates DNA resection at stalled replication forks by MRE11 and EXO1.

机构信息

Department of Biochemistry and Molecular Biology, The Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA.

出版信息

Nat Commun. 2022 Aug 27;13(1):5063. doi: 10.1038/s41467-022-32756-5.

DOI:10.1038/s41467-022-32756-5
PMID:36030235
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9420157/
Abstract

Suppression of nascent DNA degradation has emerged as an essential role of the BRCA pathway in genome protection. In BRCA-deficient cells, the MRE11 nuclease is responsible for both resection of reversed replication forks, and accumulation of single stranded DNA gaps behind forks. Here, we show that the mono-ADP-ribosyltransferase PARP14 is a critical co-factor of MRE11. PARP14 is recruited to nascent DNA upon replication stress in BRCA-deficient cells, and through its catalytic activity, mediates the engagement of MRE11. Loss or inhibition of PARP14 suppresses MRE11-mediated fork degradation and gap accumulation, and promotes genome stability and chemoresistance of BRCA-deficient cells. Moreover, we show that the KU complex binds reversed forks and protects them against EXO1-catalyzed degradation. KU recruits the PARP14-MRE11 complex, which initiates partial resection to release KU and allow long-range resection by EXO1. Our work identifies a multistep process of nascent DNA processing at stalled replication forks in BRCA-deficient cells.

摘要

抑制新生 DNA 的降解已成为 BRCA 途径在基因组保护中的一个重要作用。在 BRCA 缺陷细胞中,MRE11 核酸酶负责切除反向复制叉,并在叉后积累单链 DNA 缺口。在这里,我们表明单 ADP-核糖基转移酶 PARP14 是 MRE11 的关键辅助因子。在 BRCA 缺陷细胞中复制应激时,PARP14 被招募到新生 DNA 上,并通过其催化活性介导 MRE11 的结合。PARP14 的缺失或抑制可抑制 MRE11 介导的叉降解和缺口积累,并促进 BRCA 缺陷细胞的基因组稳定性和化学抗性。此外,我们表明 KU 复合物结合反向叉,并保护它们免受 EXO1 催化的降解。KU 招募 PARP14-MRE11 复合物,该复合物启动部分切除以释放 KU,并允许 EXO1 进行长程切除。我们的工作确定了 BRCA 缺陷细胞中停滞复制叉处新生 DNA 加工的多步过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc5/9420157/7f6483ce9ebb/41467_2022_32756_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc5/9420157/7f63303da711/41467_2022_32756_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc5/9420157/4a212e76bfd9/41467_2022_32756_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc5/9420157/55554c707dfb/41467_2022_32756_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc5/9420157/ccd4a709500a/41467_2022_32756_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc5/9420157/76dd5c08861d/41467_2022_32756_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc5/9420157/cd20f153772a/41467_2022_32756_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc5/9420157/e4c68327c25e/41467_2022_32756_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc5/9420157/7f6483ce9ebb/41467_2022_32756_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc5/9420157/7f63303da711/41467_2022_32756_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc5/9420157/4a212e76bfd9/41467_2022_32756_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc5/9420157/55554c707dfb/41467_2022_32756_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc5/9420157/ccd4a709500a/41467_2022_32756_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc5/9420157/76dd5c08861d/41467_2022_32756_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc5/9420157/cd20f153772a/41467_2022_32756_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc5/9420157/e4c68327c25e/41467_2022_32756_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc5/9420157/7f6483ce9ebb/41467_2022_32756_Fig8_HTML.jpg

相似文献

1
The KU-PARP14 axis differentially regulates DNA resection at stalled replication forks by MRE11 and EXO1.KU-PARP14 轴通过 MRE11 和 EXO1 对停滞复制叉处的 DNA 切除进行差异调节。
Nat Commun. 2022 Aug 27;13(1):5063. doi: 10.1038/s41467-022-32756-5.
2
PCAF-Mediated Histone Acetylation Promotes Replication Fork Degradation by MRE11 and EXO1 in BRCA-Deficient Cells.PCAF 介导的组蛋白乙酰化通过 MRE11 和 EXO1 促进 BRCA 缺陷细胞中的复制叉降解。
Mol Cell. 2020 Oct 15;80(2):327-344.e8. doi: 10.1016/j.molcel.2020.08.018. Epub 2020 Sep 22.
3
MRE11 and EXO1 nucleases degrade reversed forks and elicit MUS81-dependent fork rescue in BRCA2-deficient cells.MRE11核酸酶和EXO1核酸酶可降解反向叉状结构,并在BRCA2缺陷细胞中引发MUS81依赖的叉状结构挽救。
Nat Commun. 2017 Oct 16;8(1):860. doi: 10.1038/s41467-017-01180-5.
4
Human CST complex protects stalled replication forks by directly blocking MRE11 degradation of nascent-strand DNA.人 CST 复合物通过直接阻断 MRE11 对新生链 DNA 的降解来保护停滞的复制叉。
EMBO J. 2021 Jan 15;40(2):e103654. doi: 10.15252/embj.2019103654. Epub 2020 Nov 19.
5
Smarcal1-Mediated Fork Reversal Triggers Mre11-Dependent Degradation of Nascent DNA in the Absence of Brca2 and Stable Rad51 Nucleofilaments.在缺乏Brca2和稳定的Rad51核丝的情况下,Smarcal1介导的叉逆转触发Mre11依赖的新生DNA降解。
Mol Cell. 2017 Sep 7;67(5):867-881.e7. doi: 10.1016/j.molcel.2017.07.001. Epub 2017 Jul 27.
6
ATR protects ongoing and newly assembled DNA replication forks through distinct mechanisms.ATR 通过不同的机制保护正在进行和新组装的 DNA 复制叉。
Cell Rep. 2023 Jul 25;42(7):112792. doi: 10.1016/j.celrep.2023.112792. Epub 2023 Jul 16.
7
FANCD2-controlled chromatin access of the Fanconi-associated nuclease FAN1 is crucial for the recovery of stalled replication forks.范可尼贫血相关核酸酶FAN1受FANCD2调控的染色质可及性对于停滞复制叉的恢复至关重要。
Mol Cell Biol. 2014 Nov;34(21):3939-54. doi: 10.1128/MCB.00457-14. Epub 2014 Aug 18.
8
CtIP-Mediated Fork Protection Synergizes with BRCA1 to Suppress Genomic Instability upon DNA Replication Stress.CtIP 介导的叉保护与 BRCA1 协同作用,在 DNA 复制应激下抑制基因组不稳定性。
Mol Cell. 2018 Nov 1;72(3):568-582.e6. doi: 10.1016/j.molcel.2018.09.014. Epub 2018 Oct 18.
9
Cockayne syndrome group B protein regulates fork restart, fork progression and MRE11-dependent fork degradation in BRCA1/2-deficient cells. Cockayne 综合征 B 组蛋白调节 BRCA1/2 缺陷细胞中的叉重启、叉进展和 MRE11 依赖性叉降解。
Nucleic Acids Res. 2021 Dec 16;49(22):12836-12854. doi: 10.1093/nar/gkab1173.
10
Release of Ku and MRN from DNA ends by Mre11 nuclease activity and Ctp1 is required for homologous recombination repair of double-strand breaks.Mre11 核酸酶活性促使 Ku 和 MRN 从 DNA 末端释放,并且 Ctp1 对于双链断裂的同源重组修复是必需的。
PLoS Genet. 2011 Sep;7(9):e1002271. doi: 10.1371/journal.pgen.1002271. Epub 2011 Sep 8.

引用本文的文献

1
Mono-ADP-ribosylating PARP enzymes in cellular signaling and disease.细胞信号传导和疾病中的单 ADP 核糖基化 PARP 酶
J Cell Sci. 2025 Jul 15;138(14). doi: 10.1242/jcs.263963. Epub 2025 Jul 31.
2
PARP9-PARP13-PARP14 axis tunes colorectal cancer response to radiotherapy.PARP9-PARP13-PARP14轴调节结直肠癌对放疗的反应。
J Exp Clin Cancer Res. 2025 Jul 11;44(1):199. doi: 10.1186/s13046-025-03439-y.
3
The DNA-PKcs/JNK/p53 pathway underlies changes in cell fate decision toward death during DNA replication catastrophe.

本文引用的文献

1
Temporally distinct post-replicative repair mechanisms fill PRIMPOL-dependent ssDNA gaps in human cells.在人类细胞中,时间上不同的复制后修复机制填补了 PRIMPOL 依赖性单链 DNA 缺口。
Mol Cell. 2021 Oct 7;81(19):4026-4040.e8. doi: 10.1016/j.molcel.2021.09.013.
2
Loss of nuclear DNA ligase III reverts PARP inhibitor resistance in BRCA1/53BP1 double-deficient cells by exposing ssDNA gaps.核 DNA 连接酶 III 的缺失通过暴露单链 DNA 缺口使 BRCA1/53BP1 双缺陷细胞对 PARP 抑制剂耐药性逆转。
Mol Cell. 2021 Nov 18;81(22):4692-4708.e9. doi: 10.1016/j.molcel.2021.09.005. Epub 2021 Sep 22.
3
REV1-Polζ maintains the viability of homologous recombination-deficient cancer cells through mutagenic repair of PRIMPOL-dependent ssDNA gaps.
DNA依赖蛋白激酶催化亚基/应激活化蛋白激酶/抑癌基因p53信号通路是DNA复制灾难期间细胞命运向死亡转变的基础。
Nucleic Acids Res. 2025 Jun 20;53(12). doi: 10.1093/nar/gkaf573.
4
Targeting DNA damage sensors for cancer therapy.靶向DNA损伤传感器用于癌症治疗。
DNA Repair (Amst). 2025 May;149:103841. doi: 10.1016/j.dnarep.2025.103841. Epub 2025 May 2.
5
ATM priming and end resection-coupled phosphorylation of MRE11 is important for fork protection and replication restart.ATM引发及与MRE11末端切除偶联的磷酸化对于叉保护和复制重启很重要。
Proc Natl Acad Sci U S A. 2025 Apr 22;122(16):e2422720122. doi: 10.1073/pnas.2422720122. Epub 2025 Apr 18.
6
PARG inhibitor sensitivity correlates with accumulation of single-stranded DNA gaps in preclinical models of ovarian cancer.PARG 抑制剂敏感性与卵巢癌临床前模型中单链 DNA 缺口的积累相关。
Proc Natl Acad Sci U S A. 2024 Nov 19;121(47):e2413954121. doi: 10.1073/pnas.2413954121. Epub 2024 Nov 15.
7
CRISPR knockout genome-wide screens identify the HELQ-RAD52 axis in regulating the repair of cisplatin-induced single-stranded DNA gaps.CRISPR全基因组敲除筛选确定了HELQ-RAD52轴在调节顺铂诱导的单链DNA缺口修复中的作用。
Nucleic Acids Res. 2024 Dec 11;52(22):13832-13848. doi: 10.1093/nar/gkae998.
8
PARP enzymes and mono-ADP-ribosylation: advancing the connection from interferon-signalling to cancer biology.PARP 酶和单 ADP-核糖基化:将干扰素信号转导与癌症生物学的联系推进。
Expert Rev Mol Med. 2024 Aug 27;26:e17. doi: 10.1017/erm.2024.13.
9
Exo1 cooperates with Tel1/ATM in promoting recombination events at DNA replication forks.Exo1与Tel1/ATM协同作用,促进DNA复制叉处的重组事件。
iScience. 2024 Jun 28;27(8):110410. doi: 10.1016/j.isci.2024.110410. eCollection 2024 Aug 16.
10
PARP10 promotes the repair of nascent strand DNA gaps through RAD18 mediated translesion synthesis.PARP10 通过 RAD18 介导的跨损伤合成促进新生链 DNA 缺口的修复。
Nat Commun. 2024 Jul 23;15(1):6197. doi: 10.1038/s41467-024-50429-3.
REV1-Polζ 通过修复 PRIMPOL 依赖性单链 DNA 缺口来维持同源重组缺陷型癌细胞的活力。
Mol Cell. 2021 Oct 7;81(19):4008-4025.e7. doi: 10.1016/j.molcel.2021.08.016. Epub 2021 Sep 10.
4
The cell cycle effects of PARP inhibitors underlie their selectivity toward BRCA1/2-deficient cells.聚腺苷二磷酸核糖聚合酶抑制剂对细胞周期的影响是其对 BRCA1/2 缺陷细胞具有选择性的基础。
Genes Dev. 2021 Sep 1;35(17-18):1271-1289. doi: 10.1101/gad.348479.121. Epub 2021 Aug 12.
5
Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency.复制缺口是PARP抑制剂与BRCA缺陷产生合成致死性的关键决定因素。
Mol Cell. 2021 Aug 5;81(15):3227. doi: 10.1016/j.molcel.2021.07.015.
6
PARP14 regulates cyclin D1 expression to promote cell-cycle progression.PARP14 通过调节细胞周期蛋白 D1 的表达促进细胞周期进程。
Oncogene. 2021 Jul;40(30):4872-4883. doi: 10.1038/s41388-021-01881-8. Epub 2021 Jun 22.
7
Adjuvant Olaparib for Patients with - or -Mutated Breast Cancer.奥拉帕利辅助治疗 - 或 - 突变型乳腺癌患者。
N Engl J Med. 2021 Jun 24;384(25):2394-2405. doi: 10.1056/NEJMoa2105215. Epub 2021 Jun 3.
8
The emerging determinants of replication fork stability.新兴的复制叉稳定性决定因素。
Nucleic Acids Res. 2021 Jul 21;49(13):7224-7238. doi: 10.1093/nar/gkab344.
9
The Ku complex: recent advances and emerging roles outside of non-homologous end-joining.Ku 复合物:非同源末端连接以外的最新进展和新兴作用。
Cell Mol Life Sci. 2021 May;78(10):4589-4613. doi: 10.1007/s00018-021-03801-1. Epub 2021 Apr 15.
10
Nonhomologous end joining: new accessory factors fine tune the machinery.非同源末端连接:新的辅助因子精细调节机器。
Trends Genet. 2021 Jun;37(6):582-599. doi: 10.1016/j.tig.2021.03.001. Epub 2021 Mar 27.